Modulation by simvastatin of iberiotoxin‐sensitive, Ca2+‐activated K+ channels of porcine coronary artery smooth muscle cells
- 1 August 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 151 (7) , 987-997
- https://doi.org/10.1038/sj.bjp.0707327
Abstract
Background and Purpose: Statins (3‐hydroxy‐3‐methyl‐glutaryl coenzyme A (HMG CoA) reductase inhibitors) have been demonstrated to reduce cardiovascular mortality. It is unclear how the expression level of HMG CoA reductase in cardiovascular tissues compares with that in cells derived from the liver. We hypothesized that this enzyme exists in different cardiovascular tissues, and simvastatin modulates the vascular iberiotoxin‐sensitive Ca2+‐activated K+ (BKCa) channels.Experimental Approaches: Expression of HMG CoA reductase in different cardiovascular preparations was measured. Effects of simvastatin on BKCa channel gatings of porcine coronary artery smooth muscle cells were evaluated.Key Results: Western immunoblots revealed the biochemical existence of HMG CoA reductase in human cardiovascular tissues and porcine coronary artery. In porcine coronary artery smooth muscle cells, extracellular simvastatin (1, 3 and 10 μM) (hydrophobic), but not simvastatin Na+ (hydrophilic), inhibited the BKCa channels with a minimal recovery upon washout. Isopimaric acid (10 μM)‐mediated enhancement of the BKCa amplitude was reversed by external simvastatin. Simvastatin Na+ (10 μM, applied internally), markedly attenuated isopimaric acid (10 μM)‐induced enhancement of the BKCa amplitude. Reduced glutathione (5 mM; in the pipette solution) abolished simvastatin ‐elicited inhibition. Mevalonolactone (500 μM) and geranylgeranyl pyrophosphate (20 μM) only prevented simvastatin (1 and 3 μM)‐induced responses. simvastatin (10 μM) caused a rottlerin (1 μM)‐sensitive (cycloheximide (10 μM)‐insensitive) increase of PKC‐δ protein expression.Conclusions and Implications: Our results demonstrated the biochemical presence of HMG CoA reductase in different cardiovascular tissues, and that simvastatin inhibited the BKCa channels of the arterial smooth muscle cells through multiple intracellular pathways.British Journal of Pharmacology (2007) 151, 987–997; doi:10.1038/sj.bjp.0707327Keywords
This publication has 46 references indexed in Scilit:
- Relaxant effects of pravastatin, atorvastatin and cerivastatin on isolated rat aortic ringsLife Sciences, 2005
- Statin use is associated with enhanced collateralization of severely diseased coronary arteriesAmerican Heart Journal, 2003
- Effect of Protein Kinase C on Endoplasmic Reticulum CholesterolBiochemical and Biophysical Research Communications, 2002
- Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 2002
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.Journal of Clinical Investigation, 1998
- Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein.Molecular Biology of the Cell, 1996
- PKC Activity in Rat C6 Glioma Cells: Changes Associated with Cell Cycle and Simvastatin TreatmentBiochemical and Biophysical Research Communications, 1994
- Rottlerin, a Novel Protein Kinase InhibitorBiochemical and Biophysical Research Communications, 1994
- Mechanism of activation of the Ca2+-activated K+ channel by cyclic AMP in cultured porcine coronary artery smooth muscle cellsLife Sciences, 1993
- Relative rates of sterol synthesis in the liver and various extrahepatic tissues of normal and cholesterol-fed rabbitsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982